7.32Open7.32Pre Close0 Volume3 Open Interest73.00Strike Price0.00Turnover48.56%IV5.12%PremiumDec 20, 2024Expiry Date3.41Intrinsic Value100Multiplier4DDays to Expiry3.91Extrinsic Value100Contract SizeAmericanOptions Type0.8290Delta0.0667Gamma20.11Leverage Ratio-0.1337Theta0.0063Rho16.67Eff Leverage0.0199Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet